Muirhead N, Hollomby D J, Leung F Y, Mitton R, Henderson A R, Keown P A, Stiller C R
Am J Kidney Dis. 1986 Jul;8(1):51-5. doi: 10.1016/s0272-6386(86)80154-8.
Aluminum toxicity is now widely recognized as a major cause of morbidity in patients on maintenance hemodialysis. Desferrioxamine (DFO) chelation therapy has been suggested as a method of AI removal in such patients, though the most appropriate treatment schedule is yet to be established. In the present study, AI removal following DFO infusion was evaluated using two different dialyzer membranes to test the hypothesis that polyacrilonitrile (PAN) membranes permit better AI clearance. All patients studied had significantly elevated plasma AI concentrations (1.22 to 9.45 mumol/L; normal less than 0.56 mumol/L). Plasma AI did not correlate with estimated total AI intake. During hemodialysis with a cuprophane membrane, AI clearance ranged from 33.5 to 42.1 mL/min. Total AI removal was 192.2 +/- 90.4 mumol during cuprophane dialysis. During hemodialysis with a PAN membrane, AI clearance ranged from 35.7 to 54 mL/min. Total AI removal was 154.2 to 93.9 mumol during PAN dialysis. The differences in AI clearance and total AI removal were not statistically significant. It is concluded that use of a PAN membrane does not significantly enhance DFO-AI clearance.
铝中毒现已被广泛认为是维持性血液透析患者发病的主要原因。去铁胺(DFO)螯合疗法已被提议作为此类患者去除铝的一种方法,不过最合适的治疗方案尚未确定。在本研究中,使用两种不同的透析器膜评估了DFO输注后的铝去除情况,以检验聚丙烯腈(PAN)膜能实现更好的铝清除率这一假设。所有研究患者的血浆铝浓度均显著升高(1.22至9.45 μmol/L;正常低于0.56 μmol/L)。血浆铝与估计的总铝摄入量无关。在用铜仿膜进行血液透析期间,铝清除率范围为33.5至42.1 mL/分钟。在铜仿膜透析期间,总铝去除量为192.2±90.4 μmol。在用PAN膜进行血液透析期间,铝清除率范围为35.7至54 mL/分钟。在PAN膜透析期间,总铝去除量为154.2至93.9 μmol。铝清除率和总铝去除量的差异无统计学意义。结论是,使用PAN膜并不能显著提高DFO - 铝的清除率。